End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
2.86
CNY
|
0.00%
|
|
+2.88%
|
+48.19%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,894
|
4,312
|
3,724
|
4,206
|
3,483
|
2,910
|
Enterprise Value (EV)
1 |
3,832
|
5,469
|
4,592
|
4,661
|
3,958
|
3,175
|
P/E ratio
|
-5.33
x
|
-8.67
x
|
-13
x
|
14
x
|
-7.7
x
|
-6.23
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.15
x
|
3.52
x
|
2.27
x
|
3.84
x
|
13
x
|
12.6
x
|
EV / Revenue
|
1.52
x
|
4.46
x
|
2.8
x
|
4.25
x
|
14.8
x
|
13.7
x
|
EV / EBITDA
|
44.7
x
|
-28.2
x
|
47.6
x
|
-24.2
x
|
-18.5
x
|
-110
x
|
EV / FCF
|
7.04
x
|
-43.9
x
|
15.4
x
|
-1,478
x
|
-49.7
x
|
11.8
x
|
FCF Yield
|
14.2%
|
-2.28%
|
6.49%
|
-0.07%
|
-2.01%
|
8.49%
|
Price to Book
|
0.92
x
|
1.55
x
|
1.51
x
|
1.74
x
|
1.78
x
|
1.95
x
|
Nbr of stocks (in thousands)
|
1,507,501
|
1,507,562
|
1,507,590
|
1,507,590
|
1,507,590
|
1,507,590
|
Reference price
2 |
1.920
|
2.860
|
2.470
|
2.790
|
2.310
|
1.930
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/29/21
|
4/21/22
|
4/27/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,519
|
1,226
|
1,642
|
1,095
|
267.5
|
231.1
|
EBITDA
1 |
85.63
|
-194.1
|
96.38
|
-192.3
|
-214.1
|
-28.93
|
EBIT
1 |
-195.4
|
-460
|
-163.5
|
-328.1
|
-257
|
-70.66
|
Operating Margin
|
-7.76%
|
-37.51%
|
-9.96%
|
-29.95%
|
-96.08%
|
-30.58%
|
Earnings before Tax (EBT)
1 |
-614.4
|
-560.9
|
-389.1
|
257.1
|
-351.9
|
-456.9
|
Net income
1 |
-546.8
|
-503.9
|
-290.5
|
307.7
|
-455
|
-467.3
|
Net margin
|
-21.71%
|
-41.09%
|
-17.7%
|
28.09%
|
-170.05%
|
-202.21%
|
EPS
2 |
-0.3600
|
-0.3300
|
-0.1900
|
0.2000
|
-0.3000
|
-0.3100
|
Free Cash Flow
1 |
544.1
|
-124.7
|
298.1
|
-3.154
|
-79.6
|
269.4
|
FCF margin
|
21.6%
|
-10.17%
|
18.16%
|
-0.29%
|
-29.75%
|
116.57%
|
FCF Conversion (EBITDA)
|
635.36%
|
-
|
309.32%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/29/21
|
4/21/22
|
4/27/23
|
4/24/24
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
19.96
|
Net margin
|
-
|
EPS
2 |
0.0132
|
Dividend per Share
|
-
|
Announcement Date
|
4/26/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
937
|
1,158
|
868
|
455
|
475
|
265
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
10.95
x
|
-5.962
x
|
9.012
x
|
-2.364
x
|
-2.219
x
|
-9.17
x
|
Free Cash Flow
1 |
544
|
-125
|
298
|
-3.15
|
-79.6
|
269
|
ROE (net income / shareholders' equity)
|
-15.4%
|
-18.5%
|
-13.5%
|
8.84%
|
-18.4%
|
-28.7%
|
ROA (Net income/ Total Assets)
|
-1.73%
|
-5.05%
|
-1.97%
|
-4.69%
|
-4.57%
|
-1.47%
|
Assets
1 |
31,532
|
9,970
|
14,761
|
-6,556
|
9,959
|
31,843
|
Book Value Per Share
2 |
2.100
|
1.840
|
1.630
|
1.600
|
1.300
|
0.9900
|
Cash Flow per Share
2 |
0.3400
|
0.1900
|
0.2800
|
0.1000
|
0.0400
|
0.0500
|
Capex
1 |
316
|
229
|
188
|
144
|
62.5
|
37.2
|
Capex / Sales
|
12.54%
|
18.7%
|
11.46%
|
13.12%
|
23.36%
|
16.09%
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/29/21
|
4/21/22
|
4/27/23
|
4/24/24
|
|
1st Jan change
|
Capi.
|
---|
| +48.19% | 597M | | -19.34% | 1.76B | | +5.73% | 1.18B | | +0.74% | 995M | | -8.82% | 618M | | +29.91% | 580M | | +7.40% | 265M | | -35.19% | 219M | | +14.62% | 213M | | +10.63% | 190M |
Commodity Chemicals Wholesale
|